Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000618605 | SCV000736909 | uncertain significance | Cardiovascular phenotype | 2017-09-14 | criteria provided, single submitter | clinical testing | The p.I18205T variant (also known as c.54614T>C), located in coding exon 153 of the TTN gene, results from a T to C substitution at nucleotide position 54614. The isoleucine at codon 18205 is replaced by threonine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genetics and Genomics Program, |
RCV001293051 | SCV001434031 | likely benign | Hypertrophic cardiomyopathy | criteria provided, single submitter | research | ||
Revvity Omics, |
RCV003139944 | SCV003821790 | uncertain significance | not provided | 2022-01-03 | criteria provided, single submitter | clinical testing |